BDSI

BioDelivery Sciences International, Inc. News Headlines

$7.42
*  
0.02
 negative 
0.27%
Get BDSI Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

BioDelivery Sciences' Clonidine in Phase III Study - Analyst Blog
4/4/2014 6:25:01 PM - Zacks.com

BioDelivery: First Patient Enrolled In Clonidine Topical Gel Phase 3 Study
4/3/2014 7:14:00 AM - RTT News

BioDelivery Sciences: 4 Different Insiders Have Sold Shares This Month
3/31/2014 3:45:00 AM - Seeking Alpha

BioDelivery Sciences and Quintiles Sign Deal for Bunavail - Analyst Blog
3/28/2014 11:30:01 AM - Zacks.com

Pipeline Update from BioDelivery Sciences - Analyst Blog
3/18/2014 5:00:01 PM - Zacks.com

IDIX Sues GILD, ICPT Shows POISE, Watch Out For BDSI, SCMP Takes A Hit
3/16/2014 11:02:00 PM - RTT News

Weekly CEO Sells Highlight: Vringo Inc, Medivation Inc, BioDelivery Sciences International Inc ...
2/2/2014 8:37:08 PM - GuruFocus

BioDelivery Sciences International (BDSI) Soars: Stock Up 50.6% - Tale of the Tape
1/27/2014 9:51:01 AM - Zacks.com

Can The Uptrend Continue for BioDelivery Sciences (BDSI)? - Tale of the Tape
1/27/2014 8:01:01 AM - Zacks.com

Positive Results on Endo/BDSI Candidate - Analyst Blog
1/24/2014 5:45:01 PM - Zacks.com

Pipeline Update from BioDelivery Sciences - Analyst Blog
1/14/2014 7:50:01 PM - Zacks.com

Stock Watch Monday, 13 January 2014: Intercept Soars As Focus Shifts To Healthcare Market Trends
1/13/2014 9:06:00 AM - Seeking Alpha

BioDelivery Sciences (BDSI) in Focus: Stock Adds 10.9% in Session - Tale of the Tape
12/4/2013 9:37:01 AM - Zacks.com

FDA Agrees to BDSI's Phase III Program - Analyst Blog
12/3/2013 11:53:56 AM - Zacks.com

Reckitt Benckiser Sues BioDelivery Sciences And Creates A Short Opportunity
11/6/2013 9:22:00 AM - Seeking Alpha

With The FDA Reviewing Bunavail, BioDelivery Might Be A Buy
10/29/2013 9:49:00 AM - Seeking Alpha

Update on BioDelivery Sciences' Bunavail - Analyst Blog
10/11/2013 9:42:01 AM - Zacks.com

Update on BEMA Buprenorphine - Analyst Blog
9/5/2013 11:52:09 AM - Zacks.com

BioDelivery Sciences Posts Loss Y/Y - Analyst Blog
8/14/2013 11:31:10 AM - Zacks.com

BioDelivery Announces $20M Debt Financing - Analyst Blog
7/10/2013 4:45:01 PM - Zacks.com

BioDelivery Sciences' Debt Deal Puts Inflection Points Within Range
7/10/2013 12:19:00 PM - Seeking Alpha

BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
5/28/2013 7:57:00 AM - Seeking Alpha

Hedge Funds Are Buying These 3 Biotech Small Caps Trading Below Lowest Target Price
5/1/2013 10:12:00 AM - Seeking Alpha

BioDelivery On Track For Mid-Year NDA Filing
4/10/2013 8:26:00 AM - Seeking Alpha

3 Companies Aiming For The $1.2B Opioid Addiction Market
4/7/2013 5:24:00 PM - Seeking Alpha